#Gilead reports 'positive #data ' on #remdesivir coronavirus drug trial - Shares of Gilead #stocks were halted in pre- #markets trading on expectations that the healthcare application development company stock price will surge #WednesdayMotivation  @CNBC  https://t.co/iu3z6La4yF